About Us
Our Services
Technologies
- FLEXITAB
- Fluid Bed
News
- News
- Events
Careers
Contact

About Us
Our Services
Technologies
- FLEXITAB
- Fluid Bed
News
- News
- Events
Careers
Contact

JOIN US AT GPHA OCTOBER 24 – 26!

Print
Email

Conferences & Trade Shows

March 16, 2016

2016 Fall Technical Conference Bethesda North Marriott Hotel and Conference Center North Bethesda, MD

Contact Tedor Pharma

We’d like to hear more about how TEDOR can help out on your solid dose project. Fill out the form below and a TEDOR representative will contact you shortly.

Dosage Forms
- Tablet
- Capsule
Dose Characteristics
- Immediate Release
- Controlled Release
- Delayed Release
- Extended Release
- Hot Melt Extrusion
- Abuse Deterrent
- Pellets (Tablet or Capsule)
- Fast Dissolving
- Flexitab™
Development Services
- Analytical Services (Method Development and Method Validation)
- Formulation Development
- Abuse Deterrent Formulation Development
- Formulation using Poorly soluble API
- Formulation of a Controlled release dosage form
- Formulation of a Delayed release dosage form
Manufacturing Services
- Technology Transfer
- Commercial Manufacturing
- Clinical Trial Material Manufacturing (PI-PIII)
- API Sourcing
- Excipients Sourcing
- RLD Sourcing
What challenges are you facing with your solid dose project? Be specific as possible.*
Name*
Company*
Phone*
Email*
Verification

Contact

400 Highland Corporate Drive
Cumberland, RI 02864 US
(401) 405-3000
(401) 658-5263
info@tedor.com

Join Tedor

Vice President, Quality Assurance and Regulatory Affairs
Production Technician
Analytical Development Chemist

Connect

Copyright © 2019 Tedor Pharma, Inc. All rights reserved. All content property of Tedor Pharma Inc.

Start typing and press Enter to search

TEDOR PHARMA, INC. NAMES CARL E. WOOTEN AS PRESIDENT & CEONews